The Children's Hospital at Westmead
About us Parents Children Professionals Research e-Shop!
search our site
go
feedback     sitemap
  gap for health
  telehealth
  clinics
  services
Allied Health
Biochemical Genetics
Burns Unit
CAAH
CHISM
CKR
Cleft Palate Clinic
Cystic Fibrosis
Endocrinology
Gene Therapy
Malignant Hyperthermia
Neurology
Newborn Screening
Occupational Therapy
Oncology
Ponseti Clubfoot Clinic
Rehabilitation Department
Sleep Medicine
Transition Services
Tumour Bank
  education
  handbook
  pin
  nursing clinical placements
Professionals
  Home / Professionals / Services / Endocrinology / Profile: Martin Silink

Martin Silink AM MB BS (Hons1) (Usyd) MD (Usyd) FRACP

President, International Diabetes Federation
Professor of Paediatric Endocrinology

Professor Martin Silink

University of Sydney, Australia

Welcome to my web-page which contains information about my interests and activities.

Please see also the ISPAD (International Society of Pediatric and Adolescent Diabetes) Consensus Guidelines for the Management of Type 1 Diabetes which are available in Chinese, English, French, Italian, Polish, Romanian, Spanish and Turkish.

Contact Details

Email:

martin@idf.org; martins@chw.edu.au

Telephone:

+61 2 9845 3172

Fax:

+61 2 9845 3170

Address:

Institute of Endocrinology and Diabetes
University of Sydney
The Children's Hospital at Westmead
Locked Bag 4001
Westmead, NSW, 2145
Australia

Curriculum Vitae / Personal Statements (Downloads) Adobe Acrobat PDF

Background Details

Martin Silink AM MB BS Hons 1 MD MRACP FRACP

Member Order of Australia (AM)
Paul Harris Fellow (Rotary International)

Born:

Bandung, Java, Indonesia, 22nd June 1942

Nationality:

Australian

Married:

Dr Yvonne Margaret Silink BA Hons 1 PhD MACE

Children:

4

Attended:

North Sydney Boys High School and Monaro High School in NSW

Graduated:

MB BS (Hons 1, University medal) USyd 1965, MD USyd 1974

Postgraduate training:

The Children's Hospital of Philadelphia and
The Department of Biochemistry, University of Pennsylvania

Current Positions

Professor of Paediatric Endocrinology (1992 - )
Institute of Endocrinology and Diabetes
Faculty of Medicine
University of Sydney, NSW 2006, Australia

Senior Staff Specialist
Institute of Endocrinology and Diabetes
The Children's Hospital at Westmead
Locked Bag 4001
Westmead, NSW 2145, Australia

Member Order of Australia (AM)
Paul Harris Fellow (Rotary International)
Honorary Member Juvenile Diabetes Research Foundation Australia

Honorary Associate Physician, Royal Prince Alfred Hospital (1976 - )
Honorary Staff Specialist, Westmead Hospital (1978 - )
VMO Liverpool District Hospital (1992 - )
VMO Greater Murray Area Health Service (1998 - )
VMO Canberra Hospital (1998 - )
VMO Macquarie Area Health Service (1998 - )
VMO Northern Rivers Area Health Service (1998 - )

President Elect International Diabetes Federation (2003 - 2006)
Chairman IDF Child Sponsorship Programme (2000 - )
Chairman IDF WPR Childhood and Adolescent Diabcare Project 2001 (2001 - )
Chairman IDF WPR Childhood and Adolescent Diabcare Project 2003 (2003 - )

Chairman Australian Guidelines on the Management of Type 1 Diabetes in Childhood and Adolescence (2003 - )

Editor
Type 2 Diabetes in Adolescence (publisher Martin Dunitz)

Editorial Board
Pediatric Diabetes, Clinical Pediatric Endocrinology, IDF Diabetes Atlas

Advisory Board
Kuwait Foundation for the Advancement of Sciences (KFAS)
Center for Research & Treatment of Diabetes (CRTD)

Professional Societies

American Diabetes Association
Australian Diabetes Society
Australasian Paediatric Endocrine Group
Asia-Pacific Pediatric Endocrine Society
Endocrine Society of Australia
European Association for the Study of Diabetes
Hungarian Diabetes Society (Honorary)
International Diabetes Federation
International Society of Pediatric and Adolescent Diabetes
Lawson Wilkins Pediatric Endocrine Society
The Endocrine Society (USA)

Previous Appointments

Written Examination Committee, Royal Australasian College of Physicians (1979 - 1981)
Member, Council of the Australian Diabetes Society (1979 - 1981)
Member, Council of Paediatric Research Society of Australia (PRSA) (1976 - 1979)
Representative of PRSA. on Council of Australian College of Paediatrics (1976 - 1977)
Representative of Australian College of Paediatrics to Council PRSA (1978 - 1979)
Member, Council of Australian College of Paediatrics (1978 - 1979)
Secretary, NSW State Committee of Australian College of Paediatrics (1979 - 1981)
Member, NSW State Committee Australian College of Paediatrics (1978 - 1981)
ACP Representative to RACP Liaison Committee (1979)
ADS Representative to RACP Liaison Committee (1980)
ACP Subcommittee on Neonatal Thyroid Screening Programme (1978 - 1986)
Medical Advisory Board of NSW Diabetic Association (1977 - 1981)
Representative for South East Asia on International Diabetes Federation Subcommittee on Diabetes in Youth (1979 - 1981)
Assessor on NH&MRC Panel of Assessors (1977 - 1998)
Member Scientific Advisory Committee, Kellion Diabetes Foundation (1984 - )
Member Board of Directors, Children's Medical Research Institute, Sydney (1986 - 1995)
Medical Panel - Diabetes Australia
"Diabetes in Children and Adolescents Panel" - APSSEAR Advisory Expert Panel. Australian College of Paediatrics (1987)
Chairman, Medical Scientific Advisory Board, Juvenile Diabetes Foundation Australia (1987 - 1998)
NH&MRC Expert Panel on Diabetes (1989 - 1994)
Council Member - International Society for Paediatric and Adolescent Diabetes (1991 - 1994)
Liaison Officer between International Society for Paediatric and Adolescent Diabetes & International Diabetes Federation (IDF) (1992 - 1998)
Member, Specialist Advisory Committee on Endocrinology - Royal Australasian College of Physicians (1987 - 1992)
Member Australian Diabetes Society Subcommittee on Diabetes Centres and the Implementation of DCCT Strategy (1993 - 1995)
Co-Convenor, International Diabetes Federation Consultative Section on Childhood and Adolescent Diabetes (1994 - 1996)
Council Member Australasian Paediatric Endocrine Group (1995 - 1997)
Co-opted member, IDF Board of Management and Executive Council (1997 - 2000)
Member, Medical Educational Scientific Advisory Group on Diabetes to the Federal Minister of Health (1996 - 2000)
Chairman, Scientific Committee of Prostate Cancer Foundation (1995 - 1997)
Senior examiner Australian Medical Educational Council (1996 - )
Member NHMRC Expert Committee on Day Surgery and Diabetes
President International Society of Paediatric and Adolescent Diabetes (1999 - 2002)
Assessor of Endocrine Laboratories, National Association of Testing Authorities (2000 - )
Vice President, International Diabetes Federation (2000 - 2003)
Chairman of IDF Consultative Section on Childhood and Adolescent Diabetes (1994 - 2003)

Invited Lectures

  1. Plenary Lecture. Hypoglycaemia in Childhood. NZ Society for Study of Diabetes, Hamilton, NZ. 1978
  2. Visiting Professor. Home Blood Glucose Monitoring in Children. Symposium on Diabetes Management in the 80's. The Rockefeller University New York, USA. 1980
  3. Symposium Lecturer. The Infant of a Diabetic Mother. Combined meeting of ADS and NZ Society for the Study of Diabetes, Christchurch, NZ. 1981
  4. Invited Participant and Session Chairman 6th Beilinson Conference on Future Trends in Diabetes. Tel Aviv, Israel. 1984
  5. Visiting Lecturer. Master of Medicine Course, University of Singapore, 1986
  6. Visiting Lecturer. ISGD Sponsored International Update on Juvenile Diabetes Mellitus & Pediatric Endocrinology. All India Institute of Medical Sciences, New Delhi, India. 9-11 Nov 1991
  7. Invited Lecturer. Alternative Methods of Diagnosis of Growth Hormone Deficiency. Novo Nordisk Workshop on Growth. Oct 4-5, 1991
  8. Visiting Lecturer. Hypoglycaemia in Childhood. Dept of Paediatrics, University of Singapore, 30th June 1992
  9. Invited Lecturer. Alternative Methods of Diagnosis of Growth Hormone Deficiency International Perspectives on Growth Hormone. Satellite Meeting of 61st Annual Meeting of the Royal College of Physicians and Surgeons of Canada. Ottawa, Canada. 10th September 1992
  10. Plenary Lecturer. Indian Endocrine Society Annual Scientific Meeting - Paediatric Update. November 1993
  11. Plenary Lecturer. ASEAN Federation of Endocrine Societies, Kuala Lumpur. November 1993
  12. Visiting lecturer. ISPAD Postgraduate Course in Paediatric Endocrinology and Diabetes, Beijing. October 1994
  13. Plenary Lecturer. How to Improve Care of Children with Diabetes. Annual Scientific Meeting of the International Society for Paediatric and Adolescent Diabetes, Japan. November 1994
  14. Invited Lecturer. Diabetic Ketoacidosis. International Diabetes Federation Meeting, Kobe, Japan. November 1994
  15. Symposium Lecturer. Childhood Diabetes. International Paediatric Association Congress, Cairo. September 1995
  16. 4th Laron Lecturer. Invited plenary lecture. Hypophosphataemic Rickets. Sackler University, Tel Aviv, Israel. October 1995
  17. Plenary Lecture. Strategies to prevent Diabetes Complications other than glycaemic control. International Society of Paediatric & Adolescent Diabetes, Pittsburgh. June 1996
  18. Plenary Lecture. Pathophysiology of Diabetic Ketoacidosis. Special Paediatric Session. Third IDF Western Pacific Regional Congress, Hong Kong. September 1996
  19. Symposium Lecture. Congenital Adrenal Hyperplasia. International Society Diabetes and Endocrine Diseases in the Young, Chiang Mai, Thailand, January 1997
  20. Symposium Lecture. Diabetes Management in the Very Young. International Society Diabetes and Endocrine Diseases in the Young, Chiang Mai, Thailand. January 1997
  21. Plenary Lecture. Growth Hormone Therapy. Philippine Paediatric Endocrine Society. February 1997
  22. Plenary Lecture. Congenital Adrenal Hyperplasia. Philippine Paediatric Endocrine Society. February 1997
  23. Symposium Lecture. Hypophosphataemic Rickets. 9th Asian Congress of Paediatrics, Hong Kong. March 1997
  24. Plenary Lecture. Diabetic Ketoacidosis. International Society of Paediatric and Adolescent Diabetes, Turku, Finland. July 1997
  25. Symposium Lecture. IDF Policies on Childhood and Adolescent Diabetes, IDF Congress, Helsinki, Finland. July 1997
  26. Symposium Lecture. Macrovascular Disease in Childhood Diabetes. Diabetes Angiopathy Congress, Berlin, Germany. September 1997
  27. Plenary Lecture. Diabetic Ketoacidosis. International Symposium on Diabetes, Copenhagen, Denmark. November 1997
  28. Plenary Lecture. Management of Ketoacidosis and Acid Base Balance. Israel Diabetes Society. March 1998
  29. Symposium Lecture. Growth Hormone usage in Non Growth Hormone Deficiency. Asia and Oceania Congress of Endocrinology, Seoul, Korea. April 1998
  30. Convenor of IDF Workshop on Childhood and Adolescent Diabetes. Phuket, Thailand. April 1998
  31. Plenary Lecture. Endocrine responses in critical illness. 20th Annual Congress of the Malaysian Paediatric Association. July/August 1998
  32. Symposium Lecture. Hypoglycaemia - Recent Advances. 20th Annual Congress of the Malaysian Paediatric Association. July/August 1998
  33. Symposium Lecture. Infantile hypoglycaemia - Therapeutic approach. 20th Annual Congress of the Malaysian Paediatric Association. July/August 1998
  34. Plenary Lecture. Psychosocial Issues - An International Perspective. Third National Assembly for Diabetes Trainers, Philippines. November 1998
  35. Plenary Lecture. Recent Advances in type 1 Diabetes. Third National Assembly for Diabetes Trainers, Philippines. November 1998
  36. Convenor of IDF Leadership Needs Assessment Workshop on Childhood and Adolescent Diabetes, Tunis, Tunisia. March 1999
  37. Lecturer. IDF Consultative Section on Diabetes Education Workshop. Bangkok, Thailand. November 1999
  38. Plenary Lecture. Optimising Diabetes Control/Lessons from monitoring. Asean Federation of Endocrine Societies, Bangkok, Thailand. December 1999
  39. Symposium Lecturer. Growth and Diabetes. Indonesian Endocrine Society, Bandung, Indonesia. April 2000
  40. Plenary Lecture. Diabetic ketoacidosis in childhood. Hungarian Diabetes Society, Hungary. April 2000
  41. Invited lecture. Genes and Diabetes Complications. University of Pecs, Hungary. April 2000
  42. Meet the Professor Session. When to start testing for complications. American Diabetes Association, San Antonio. June 2000
  43. State of the Art Lecture. Type 2 Diabetes in Childhood and Adolescence. European Association for the Study of Diabetes (EASD), Jerusalem. September 2000
  44. Symposium Speaker. Childhood and Adolescent Diabetes. 2nd Hong Kong Diabetes & Cardiovascular Risk Factors East Meets West, Hong Kong. September 2000
  45. Plenary Lecture. Childhood and Adolescent Diabetes. 17th International Diabetes Federation Congress, Mexico City. November 2000
  46. Lecturer at the Science School 2000. International Society for Pediatric and Adolescent Diabetes (ISPAD), Berlin. December 2000
  47. Invited lecturer. Diabetic Ketoacidosis. Japanese Diabetes Society and Japanese Study Group on Insulin Therapy. Tokyo and Osaka, Japan. February 2001
  48. Invited lecturer. Models of Care. Japanese Diabetes Society and Japanese Study Group on Insulin Therapy. Tokyo and Osaka, Japan. February 2001
  49. Invited lecturer. Management of Childhood and Adolescent Diabetes. Japanese Diabetes Society and Japanese Study Group on Insulin Therapy. Tokyo and Osaka, Japan. February 2001
  50. Plenary Lecture. The Global Evolution of Childhood Diabetes. Conference on Diabetes in the Arab World, Bahrain. March 2001
  51. Invited Symposium lecturer. Global Evolution of Childhood and Adolescence Diabetes. Kuwait Institute for Medical Specialization (KIMS) and the Faculty of Medicine, Kuwait University. April 2001
  52. Invited Symposium lecturer. Diabetic ketoacidosis revisited. Kuwait Institute for Medical Specialization (KIMS) and the Faculty of Medicine, Kuwait University. April 2001
  53. Invited Symposium lecturer. Intensified Management of Childhood and Adolescent Diabetes. Kuwait Institute for Medical Specialization (KIMS) and the Faculty of Medicine, Kuwait University. April 2001
  54. Plenary Lecture. Recent Advances In Diabetes Mellitus. Lebanon Diabetes Society . July 2001
  55. Plenary Lecture. Diabetic Ketoacidosis. Lebanon Diabetes Society. July 2001
  56. Symposium Lecture. Intersex. 23rd International Congress of Pediatrics, Beijing. September 2001
  57. Symposiun Lecture. ISPAD/IDF Perspectives on Childhood and Adolescent Diabetes. 23rd International Congress of Pediatrics, Beijing. September 2001
  58. Lecture. Investigation and Management of Hypoglycaemia. Conference on Child Health and The 9th Conference of the Union of Arab Pediatric Societies. November 2001
  59. Plenary Lecture. Recent Advances in Diabetes Mellitus. Conference on Child Health and The 9th Conference of the Union of Arab Pediatric Societies. November 2001
  60. Meet the Expert Sesssion. Diabetic Ketoacidosis Revisited. Conference on Child Health and The 9th Conference of the Union of Arab Pediatric Societies. November 2001
  61. Lecturer at the Science School 2000. International Society for Pediatric and Adolescent Diabetes (ISPAD). Lisbon, Portugal. December 2001
  62. Plenary Lecture. Childhood Diabetes as a Model of a Hidden Chronic Disease. University of Ain Shams, Cairo, Egypt. March 2002
  63. Plenary Lecture. Recent Trends in the Management of Type 1 Diabetes. Egyptian Diabetes Society, Cairo, Egypt. March 2002
  64. Symposium. Recent Advances in Type 1 Diabetes. Indonesian Pediatric Association Meeting and ASEAN Federation of Pediatric Societies Meeting, Bali, Indonesia. July 2002
  65. Plenary Lecture. Life Styles and Obesity Associations with type 2 Diabetes - a paediatric perspective. Diabetes in Asia 2002, Colombo, Sri Lanka. July 2002
  66. Symposium. X-linked Hypophosphataemic Rickets. Asia Pacific Paediatric Endocrine Society, Cairns, Australia. November 2002
  67. Plenary Lecture. New Insulins and Delivery Modes. Asia Pacific Paediatric Endocrine Society, Cairns, Australia. November 2002
  68. Plenary Lecture. The Global Evolution of Childhood Diabetes. The Ibrahim Oration. Bangladesh Diabetes Society, Dhaka, Bangladesh. December 2002
  69. Symposium Lecture. The management of Cardiovascular Risk Factors in Type 2 Diabetes in Adolescents. IDF Workshop on type 2 diabetes in Adolescents, Los Angeles. February 2003
  70. Symposium Lecture. Advances in Chronic Disease and the Impact on Quality of Life. 3rd Congress on Child & Youth Health, Vancouver, Canada. May 2003
  71. Plenary Lecture. IDF Sponsor a Child. Rotary International, Perugia, Italy. November 2003
  72. Symposium Lecture. The Global Evolution of Childhood & Adolescent Diabetes. 11th Asian Congress of Pediatrics, Bangkok, Thailand. November 2003
  73. Plenary Lecture. The Impact of Diabetes in the Western Pacific. World Diabetes Day. Fijian Diabetes Association, Fijian Department of Health, Fiji. November 2003.
  74. Plenary Lecture. The Challenges of Childhood Diabetes. Philippine Diabetes Association, Manila, Philippines. November 2003
  75. The 12th Servier Lecture. The Future Impact of Diabetes. The Philippine Center for Diabetes Education & The Philippine Diabetes Association, Manila, Philippines. November 2003
  76. Plenary Lecture. Evidence based guidelines for type 1 diabetes in children and adolescents. 5th Diabetes in Asia Conference, Karachi, Pakistan. April 2004
  77. Plenary Lecture. International Diabetes Federation. German Diabetes Association, Hannover, Germany. May 2004
  78. Keynote Lecture. The Role of International Organisations in Pediatric Endocrinology. 3rd Asia Pacific Paediatric Endocrine Society (APPES) Scientific Meeting, Kobe, Japan. September 2004
  79. Symposium Lecture. Evidence-based guidelines for type 1 diabetes in children and adolescents. 3rd Asia Pacific Paediatric Endocrine Society (APPES) Scientific Meeting, Kobe, Japan. September 2004
  80. Keynote Lecture. The Global Impact of Diabetes. 1st International Conference on Diabetes of Upper Egyptian Universities. Luxor, Egypt. January 2005
  81. Meet the Professor Workshop on Intensified Insulin Therapy. 1st International Conference on Diabetes of Upper Egyptian Universities. Luxor, Egypt. January 2005
  82. Keynote Speech. The Global Impact of Diabetes. Gulf Group for the Study of Diabetes Conference. Dubai, United Arab Emirates. February 2005
  83. Symposium Lecture. Evidence-based Clinical Practice Guidelines for type 1 diabetes in Children and Adolescents. Gulf Group for the Study of Diabetes Conference. Dubai, United Arab Emirates. February 2005
  84. Meet the Professor. Intensified Control in Childhood and Adolescent Diabetes: How Good Is It? Gulf Group for the Study of Diabetes Conference. Dubai, United Arab Emirates. February 2005
  85. Symposium Lecture. Diabetic Ketoacidosis. Gulf Group for the Study of Diabetes Conference. Dubai, United Arab Emirates. February 2005
  86. Plenary Lecture. The Importance of Associations for People with Diabetes - A Global View. X Brazilian Multidisciplinary, Multiprofessional Congress July 2005
  87. Plenary Lecture. The Importance of IDF and of Continuous Education for Health Professionals. X Brazilian Multidisciplinary, Multiprofessional Congress. Sao Paulo, Brazil. July 2005
  88. Plenary Lecture. Global Impact of Diabetes. X Brazilian Multidisciplinary, Multiprofessional Congress. Sao Paulo, Brazil. July 2005
  89. Symposium Lecture. IDF - Diabetes Educaton. X Brazilian Multidisciplinary, Multiprofessional. Sao Paulo, Brazil. Congress July 2005
  90. Plenary Lecture. Global Impact of Diabetes. ISPAD 31st Annual Meeting Krakow, Poland. September 2005
  91. Plenary Lecture. Improving Diabetes Care. ESPE/WLPES 2005 - 7th Joint Meeting Paediatric Endocrinology. Lyon France. September 2005
  92. Symposium Lecture. Global Impact of Diabetes. IDF WPR Congress 2005. Bangkok, Thailand. October 2005
  93. Sir Frank Gunasekera Memorial Oration. The Good Life and Mankind's biggest Epidemic. Rotadiab (Sri Lanka) & National Diabetes Centre Sri Lanka. Colombo, Sri Lanka. November 2005
  94. Plenary Lecture.The Global Impact of Diabetes - The Case for a UN Resolution on Diabetes. 2nd International Diabetes India Conference. Jaipur, India. November 2005
  95. Plenary Lecture. Challenges of Intensified Insulin Treatment in Children and Adolescents. 2nd International Diabetes India Conference. Jaipur, India. November 2005
  96. Keynote Speaker. Diabetes and the Young. Diabetes Summit & WPDD. Hanoi, Vietnam. February 2006
  97. Keynote Lecture. The Case for a United Nations Resolution. 50th Anniversary Celebrations, Diabetic Association of Bangladesh. Dhaka, Bangladesh. February 2006
  98. Keynote Speaker. The Global Impact of Diabetes - Rotary's Support for a UN Resolution on Diabetes. Rotary Conference. Hobart, Tasmania. March 2006
  99. Special Lecture. The Campaign for a United Nations Resolution on Diabetes. 2006 Health Symposium - Diabetes Australia. Brisbane, Queensland. March 2006
  100. Plenary Lecture. The Case for a United Nations Resolution on Diabetes. Diabetes New Zealand Conference 2006. Christchurch, New Zealand. May 2006
  101. Plenary Lecture. The Global Impact of Diabetes - The Case for a United Nations Resolution on Diabetes. 49th Annual Meeting of the Japan Diabetes Society. Tokyo, Japan. May 2006
  102. Plenary Lecture. UN Resolution on Diabetes. Annual Scientific Meeting, Federation of Diabetes Associations, Sao Paulo, Brazil. July 2006
  103. Keynote Address. UN Resolution on Diabetes. Annual Scientific Meeting of International Society of Pediatric and Adolescent Diabetes (ISPAD). Cambridge, England. September 2006.
  104. Plenary Lecture. UN Resolution on Diabetes. Federation of European Nurses in Diabetes (FEND), Copenhagen, Denmark. September 2006
  105. Plenary Lecture. The International Politics of Diabetes. Scientific Meeting, Kuwait Diabetes Soceity, Kuwait. November 2006
  106. Plenary Lecture (Gold Medal Oration). The Fight for a UN Resolution on Diabetes. Dr Mohan Diabetes Centre, Chennai, India. February 2007
  107. Plenary Lecture. UN Resolution on Diabetes. The Gulf States Diabetes Study Group. Muscat, Oman. February 2007

Publications

  1. Silink M, Vines R. Diabetic Ketoacidosis in Childhood. Med J Aust 1973;1:250-252
  2. Silink M, Reddel R, Bethel M, Rowe PB. Gamma Glutamyl Hydrolase (Conjugase). Purification and Properties of the Bovine Liver Enzyme. J Biol Chem 1975;250:5982-5994
  3. Silink M, Rowe PB. The Localisation of Glutamate Carboxypeptidase in Rat Liver Lysosomes. Biochem Biophys Acta 1975;381:28-36
  4. Rowe PB, Silink M and Reddel R. The Properties of Gamma Glutamyl Hydrolase (Conjugase) from Bovine Liver in Chemistry and Biology of Pteridines (ed. Pfleiderer, W.) pp 85-92, Walter de Gruyter, New York, 1976
  5. Silink M. Sexual Differentiation and Genital Anomalies. Med J Aust 1977;1:660-662
  6. Truscott R, Pullin C, Halpern B, Wilcken B, Silink M, Griffiths H, Kilham H, Grunseit F. Suspected defect in fatty acid oxidation. New Eng Jour Med 1978;299:152
  7. Smith A, Silink M, Ruxton T. Trisomy 18 in an eleven year old girl. J Ment Defic Res 1978;22:277-286
  8. Truscott R, Hick L, Pullin C, Halpern B, Wilcken B, Griffiths H, Silink M, Kilham H, Grunseit F. Dicarboxylic Aciduria: Response to Fasting. Clin Chim Acta 1979;94(1):31-39
  9. Kreutzmann D, Vines RH, Hensley WJ, Silink M. Diagnosis of 11 Beta Hydroxylase Deficiency in Two Children with Congenital Adrenal Hyperplasia. Aust J Paediatr 1979;15:36-38
  10. Kozlowski K, Prokop B, Scougall J, Silink M, Vines R. Spondylo-Metaphyseal Dysplasia (Report of a case of common type and three cases of "New Varieties"). Fortschr Rontgenstr 1979;130(2):222-230
  11. Kitson H, McCrossin R, Jimenez M, Middleton A, Silink M. Somatostatin Treatment of Insulin Excess Due to Beta Cell. Adenoma in a Neonate. J Pediatr 1980;96:145-151
  12. Smith A, Farrar JR, Silink M, Judzewitsch R. Dominant Sotos' Syndrome. Arch Dis Child 1980 Letter 55:579
  13. Eross J, Silink M, Dorman D. Cerebrospinal Fluid Lactic Acidosis in Bacterial Meningitis. Arch Dis Child 1981;56:692-698
  14. Ouvrier R, Lewis D, Procopis PG, Billson FA, Silink M, De Silva M. Bilateral Optic Nerve Hypoplasia. Clin Exp Neurol 1981;18:52-60
  15. Smith A, Farrar JR, Silink M, Judzewitsch R. Investigations in dominant Sotos syndrome. Ann Genet (Paris) 1981;24(4):226-8
  16. Kreutzmann D, Cam G, Silink M. Celite Multi-Column Chromatography for the Simultaneous Separation of Progesterone, Deoxycorticosterone and 17 alpha Hydroxyprogesterone from Small Plasma or Tissue Samples. J Chromato 1982;228:95-101
  17. Silink M. Home Blood Glucose Monitoring in Childhood Diabetes in Diabetes management in the '80s. (ed. Peterson CM). Praeger Publishers. U.S.A, 1982;pp.176-183
  18. Arnold JD, Oldfield RK, Pollard AC, Silink M. Primary Hypomagnesaemia. Aust Paediatr J 1983;19:45-46
  19. Eross J, Kreutzmann D, Jimenez M, Keen R, Rogers S, Cowell C, Vines R, Silink M. Colorimetric Measurement of Glycosylated Protein in Whole Blood, Red Blood Cells, Plasma and Dried Blood. Annals Clin Biochem 1984;21(6):477-483
  20. Rogers S, Silink M. Residual Insulin Secretion in Insulin Dependent Diabetes Mellitus. Arch Dis Child 1985;60:200-203
  21. Banatvala JE, Bryant J, Schernthaner G, Borkenstein M, Schober E, Brown D, DeSilva LM, Menser MA, Silink M, Coxsackie B. Mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria and Australia. Lancet 1985;22;1:1409-12
  22. Morris L, Kozlowski K, McNaught P, Silink M. Tricho-rhino-phalangeal syndrome I (report of 8 cases). Australasia Radiol 1985;29(2):167-73
  23. Eross J, Kreutzmann DJ, Cowell C, Silink M. Glycated hemoglobin measurement in dried blood on filter paper. Clin Chem 1986;32:2222
  24. Hoskins PL, Handelsman DJ, Hannelly T, Silink M, Yue DK, Turtle JR: Diabetes in the Melanesian and Indian Peoples of Fiji: a study of risk factors. Diab Res Clin Prac 1987;3:269-276
  25. Hoskins PL, Handelsman DJ, Hannelly T, Silink M, Yue DK, Turtle JR. Glycosylated haemoglobin as an Index of the Prevalence and Severity of Diabetes in Biethnic Fiji. Diab Res Clin Prac 1987;3:257-267
  26. Hoskins PL, Handelsman DJ, Hannelly T, Silink M, Alford JB, Fowler PM, Hosking M, Yue DK, Turtle JR. Glycosylated haemoglobin as an Index of the Prevalence and Severity of Diabetes in Biethnic Fiji. Diabetic Medicine 1986
  27. Cowell CT, Rogers S, Silink M. First Morning Urinary Albumin Concentration is a Good Predictor of 24 Hour Urinary Albumin Excretion in Children with Type-1 (Insulin Dependent) Diabetes. Diabetologia 1986;29:97-99
  28. Silink M, Rogers S, Vines R. Impact of Home Blood Glucose Monitoring on Residual C. Peptide Secretion in Diabetic Children. Pediatr Adolesc Endocr 1986;15
  29. Silink M. The Short Child. Mod Med 1986
  30. Kirk JA, Raghupathy P, Stevens MM, Cowell CT, Menser MA, Bergin M, Tink A, Vines RH, Silink M. Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet 1987 Jan 24;1(8526):190-193
  31. Kreutzmann DJ, Silink M. Determination of 17-Oxosteroid glucuronides and sulphates in urine by liquid chromatography using 2,4-dinitrophenylhydrazine as a prelabelling reagent for spectrophotometric detection. J Chromato 1987;415:253-260
  32. Arnold JD, Leslie GI, Williams G, Rack P, Silink M. Adrenocorticol responsiveness in neonates weaned from ventilator with dexamethasone. Aust Paediatr J 1987;23(4):227-229
  33. Cotterill A, Cowell CT, Baxter RC, McNeil D, Silink M. Regulation of the Growth Hormone-Independent Growth Factor-Binding Protein in Children. J Clin Endocri Metab 1988;67:882-887
  34. Finalyson PJ, Caterson ID, Rhodes KM, Plehwe WE, Hannelly T, Silink M. Diabetes, Obesity and Hypertension in Vanuatu. PNG Med J 1988;31(1):9-18
  35. Eross J, Kreutzmann D, Jimenez M, Silink M. Glycosylated hemoglobin measurement and sample collection paper. Diabetes Care 1988;11(8):686-687
  36. Cowell CT, Quigley CA, Moore B, Kirk JA, Bergin M, Jimenez M, Stevens MM, Howard NJ, Menser MA, Silink M. Growth and growth hormone therapy of children treated for leukaemia. Acta Paediatr Scand Suppl 1988;343:152-61
  37. Quigley C, Cowell C, Jimenez M, Burger H, Kirk J, Bergin M, Stevens M, Simpson J, Silink M. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukaemia. N Engl J Med 1989;321:143-151
  38. Crawford BA, Cowell CT, Greenacre P, Howard NJ, Stevens MM, Silink M. Carbohydrate metabolism on high dose growth hormone therapy in children treated for leukaemia. Aust Paediatr J 1989;25:236-240
  39. Sutton DL, Greenacre P, Howard NJ, Cowell CT, Silink M. Patterns of hospitalisation in a paediatric diabetes clinic in Sydney. Diabetes Res Clin Pract 1989;7:271-276
  40. Cotterill AM, Cowell CT, Silink M. Insulin and variation in glucose levels modify the secretion rates of the growth hormone-independent insulin-like growth factor binding protein-1 in the human hepatoblastoma cell line Hep G2. J Endocrinol 1989;123:R17-R20
  41. Quigley C, Cowell C, Jimenez M, Burger H, Kirk J, Bergin M, Stevens M, Simpson J, Silink M. Letter to the Editor. N Engl J Med 1989;321:1831
  42. Kreutzmann DJ, Cowell CT, Howard NJ, deSouza M, Silink M. Congenital adrenal hyperplasia family studies using the short ACTH test. Aust Paed J 1989;25:340-345
  43. Werther GA, Warne GL, Ennis G, Gold H, Silink M, Cowell CT, Quigley C, Howard N, Antony G, Byrne GC, Thomsett M, Epstein MT, Pullan PT, Perry-Keane DA, Clarke AL, Wilson F, Hudson I. Luteinizing hormone-releasing hormone analogue (Buserelin) treatment for central precocious puberty: A multi-centre trial. J Paediatr & Child Health 1990;26(1):4-8
  44. Lu PW, Cowell C, Jimenez M, Simpson J, Silink M. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome. Arch Dis Child 1991;66:1184-1190
  45. Arnold J, Leslie G, Kreutzmann D, Silink M. Longitudinal study of urinary free cortisol (UFC) in VLBW infants during the first 16 weeks. J Paediatr Child Health 1991;27:315
  46. Verge CF, Lam A, Simpson J, Cowell CTC, Howard NJ and Silink M. Effects of therapy in X-linked Hypophosphatemic Rickets. New Eng J Med 1991:325:1843-1848
  47. Fong I, Hulinsky I, Fortuna R, Silink M. Mitotic Activity and DNA Synthesis of Rat Islet Cells Following Partial Pancreatectomy. Pancreas 1992;7:453-459
  48. Lu PW, Silink M, Johnston I, Cowell CT, Jimenez M. Pituitary Gigantism. Arch Dis Child 1992;67:1039-1041
  49. Alabbasy AJ, Delbridge L, Eckstein, Cowell CT, Silink M. Microfollicular Thyroid Adenoma and Congenital Goitrous Hypothyroidism. Arch Dis Child 1992;67:1294-1295
  50. Gadd S, Silink M, Kamath KR, Skerritt JH. Co-existence of coeliac disease and insulin-dependent diabetes mellitus in children: screening sera using an ELSIA test for gliadin antibody. Aust NZ J Med 1992;22:256-260
  51. Silink M. Alternative methods of diagnosis of growth hormone deficiency. J Pediatr Endo 1992,5:43-52
  52. Schwingshandl J, Donaghue K, Howard NJ, Hing S, Simpson JM, Silink M. In Weber B, Burger W, Danne T (eds): Pupillometry in children and adolescents with type 1 diabetes. In Structural and Functional Abnormalities in Subclinical Diabetic Angiopathy. Pediatric Adol Endo Basel, Karger, 1992;22:135-141
  53. Ambler GR, Cowell CT, Quigley CA, Silink M. Growth hormone hypersecretion in Sotos syndrome? Acta Paediatr 1993;82:214-216
  54. Schwingshandl J, Sholler G, Silink M. Echocardiographic load independent indices of contractility in young patients with type 1 diabetes: effect of metabolic control and insulin on left ventricular performance. Europ J Cardiol. 1993
  55. Silink M. The Somogyi effect-the paediatric view. Med J Australia. 1993;159:483-485
  56. Verge CF, Cowell CT, Howard NJ, Donaghue KC, Silink M. Growth in children with X-linked hypophosphataemic rickets. Acta Paediatr (Suppl) 1993;388:70-75
  57. Verge CF, Donaghue KC, Williams PF, Cowell CT, Silink M. Insulin resistant diabetes during GH therapy in a child with SHORT syndrome - a case report. Acta Paediatr (Suppl). 1993;338:70-5
  58. Donaghue KC, Bonney M, Simpson JM, Schwingshandl J, Fung ATW, Howard NJ, Silink M. Autonomic and peripheral nerve function in adolescents with and without diabetes. Diabetic Medicine 1993;10:664-671
  59. Schwingshandl J, Simpson JM, Donaghue K, Bonney M, Howard NJ, Silink M. Pupillary abnormalities in type 1 diabetes occurring during adolescence: Comparisons with cardiovascular reflexes. Diabetes Care 1993;16:630-633
  60. Schwingshandl J, Donaghue K, Luttrell B, Cowell CT, Ward P, Silink M. Transient congenital hypothyroidism due to maternal thyrotrophin binding inhibiting immunoglobulin. J Paediatr Child Health. 1993;29:315-318
  61. Yue DK, Colagiuri S, McElduff A, Silink M. Diabetes Control and Complications Trial. Position statement of the Australian Diabetes Society. Med J Aust 1993;159:803-804
  62. Verge CF, Howard NJ, Irwig L, Simpson JM, Mackerras D, Silink M. Environmental factors in childhood IDDM - a population-based, case-control study. Diabetes Care 1994;17:1381-1389
  63. Verge CF, Howard NJ, Silink M. The incidence of childhood IDDM in New South Wales Australia. Diabetes Care 1994;17:693-696
  64. Wilcken B, Hammond J, Silink M. Morbidity and mortality in medium-chain acyl-coenzyme A dehydrogenase deficiency in New South Wales. Arch Dis Child 1994;70(5):410-412
  65. Fairchild JM, Hing SJ, Donaghue KC, Bonney M, Fung ATW, Stephens MM, Mitchell P, Howard NJ, Silink, M. Prevalence and risk factors for retinopathy in adolescents with type 1 diabetes. Med J Aust. 1994;160:757-762
  66. Verge CF, Howard NJ, Rowley MJ, Mackay IR, Zimmet PZ, Egan M, Hulinska H, Hulinsky I, Slvertrini RA, Kamath S, Sharp A, Arundel T, Silink M. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 1994;37:1113-1120
  67. Verge CF, Donaghue KC, Williams PF, Cowell CT, Silink M. Insulin-resistant Diabetes during Growth Hormone Therapy in a child with SHORT syndrome: A Case Report. Acta Paediatr 1994;83:786-788
  68. Ellaway CJ, Silink M, Cowell CT, Gaskin KJ, Kamath KR, Dorney S, Donaghue KC. Cholestatic jaundice and congenital hypopituitarism. J Paediatr Child Health. 1995;31(1):51-53
  69. Hulinsky I, Hulinsky H, Silink M. DNA Synthesis in cultured neonatal rat islets - a comparison of two methods. Diab Res Clin Practice, 1995;27(2):119-26
  70. Hulinsky I, Cooney S, Harrington J, Silink M. In vitro growth of neonatal rat islet cells is stimulated by adhesion to matrix. Horm Metab Res, 1995;27(5):209-215
  71. Bonney M, Hing SJ, Fung ATW, Stephens MM, Fairchild JM, Donaghue KC, Howard NJ, Silink M. Development and progression of diabetic retinopathy: Adolescents at risk. Diabetic Medicine 1995;12:967-973
  72. Pena MM, Donaghue KC, Fung ATW, Bonney M, Schwingshandl J, Howard NJ, Silink M. The prospective assessment of autonomic nerve function by pupillometry in adolescents with type 1 diabetes mellitus. Diabetic Medicine 1995;12:868-873
  73. Likitmaskul S, Cowell CT, Donaghue KC, Kreutzman DJ, Howard NJ, Blades B, Silink M. "Exaggerated Adrenarche" in children presenting with premature adrenarche. Clinical Endocrinology 1995;42:265-272
  74. Hulinsky I, Harrington J, Cooney S, Silink M. Insulin secretion and DNA synthesis of cultured islets of langerhans are influenced by the matrix. Pancreas 1995;11:309-314
  75. Couper JJ, Jones TW, Donaghue KC, Clarke CF, Thomsett MJ, Silink M. The Diabetes Control and Complications Trial. Implications for children and adolescents. Australasian Paediatric Endocrine Group. Med J Aust 1995;162(7):369-72
  76. Bonney M, Hing SJ, Fung AT, Stephens MM, Fairchild JM, Donaghue KC, Howard NJ, Silink M. Development and progression of diabetic retinopathy: adolescents at risk. Diabet Med. 1995 Nov;12(11):967-973
  77. Donaghue KC, Fung ATW, Fairchild JM, Howard NJ, Silink M. Prospective assessment of autonomic and peripheral nerve function in adolescents with diabetes. Diabet Med. 1996 Jan;13(1):65-71
  78. Schwingshandl J, Donaghue K, Fung ATW, Pena MM, Bonney M, Howard NJ, Silink M. Vascular responses by transcutaneous oximetry in adolescents with and without diabetes. J Diabetes Complications 1996;10(1):18-22
  79. Donaghue KC, Fung ATW, Hing S, Fairchild J, King J, Chan A, Howard NJ, Silink M. The effect of prepubertal diabetes duration on diabetes. Diabetes Care. 1997;20:77-80
  80. Donaghue K, Robinson J, McCredie R, Fung A, Silink M, Celermajer D. Large vessel dysfunction in diabetic adolescents and its relationship to small vessel complications. J Pediatr Endocrinol Metab 1997;10:593-598
  81. Donaghue KC, Fairchild JM, Chan A, Hing SJ, King J, Howard NJ, Silink M. Diabetes microvascular complications in prepubertal children. J Pediatr Endocrinol Metab 1997;10:579-585
  82. Arnold J, Leslie G, Bowen, Watters S, Kreutzmann D, Silink M. Longitudinal study of plasma cortisol and 17-hydroxyprogesterone in very low birth weight infants during the first 16 weeks of life. Biol Neonate 1997;72:148-155
  83. Donaghue K, Robinson J, McCredie R, Fung A, Celermajer D, Silink M. Macroangiopathy - does it play a role in young people? Hor Res 1998;50(suppl 1):38-40
  84. Kao Y, Donaghue K, Chan A, Knight J, Silink M. A Variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM. J Clin Endocrinol Metab 1998;Vol 83;7:2589-2592
  85. Silink M. Practical Management of Diabetic Ketoacidosis in Childhood and Adolescence. Acta Paediatric Scand. 1998;Suppl 425;Vol 87:63-66
  86. Arnold JD, Bonacruz G, Leslie GI, Veldhuis JD, Milmlow D, Silink M. Antenatal glucocorticoids modulate the amplitude of pulsatile cortisol secretion in premature neonates. Ped Res 1998;44:876-881
  87. Donaghue KC, Fairchild JM, Chan A, Hing SJ, Howard NJ, Silink M. Diabetes Complications Screening in 937 Children and Adolescents. J Pediatr Endocrinol Metab 1999;Vol 12:185-192
  88. Duffin AC, Donaghue KC, Potter M, McInnes A, Chan A, King J, Howard NJ, Silink M. Limited joint mobility in the hands and feet of adolescents with type 1 diabetes mellitus. Diabet Med 1999;16:125-130
  89. Donaghue KC, Silink M. Diabetic Neuropathy in Childhood. Diab Nutr Metab 1999;12:154-160
  90. Kao YL, Donaghue KC, Chan A, Knight J, Silink M. A novel polymorphism in the Aldose Reductase Gene Promotor region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes 1999;48:1338-1340
  91. Kao Y, Donaghue K, Chan A, Knight J, Silink M. An aldose reductase intragenic polymorphism associated with diabetic retinopathy. Diabetes Research Clin Pract 1999;46:155-160
  92. Craig ME, Howard NJ, Silink M, Chan A. The Rising Incidence of Childhood type 1 Diabetes in New South Wales, Australia. Jour Pediatr Endo Metab 2000;13(4):363-372
  93. Fairchild JM, Ambler GR, Genoud-Lawton CH, Westman EA, Chan A, Howard NJ, Crock PA, Nunn EA, Silink M. Insulin lispro versus regular insulin in children with type 1 diabetes on twice daily insulin. Pediatric Diabetes 2000;1:135-141
  94. Donaghue KC, Pena MM, Chan AKF, Blades BL, King J, Storlien LH, Silink M. Beneficial effects of increasing monounsaturated fat intake in adolescents with type 1 diabetes. Diab Research and Clin Practice 2000;48:193-199
  95. Kordonouri O, Kao Y, Bennetts B, James R, Danne T, Chan A, Silink M, Donaghue KC. Modulation by blood glucose levels of activity and concentration of paraoxonase in adolescents with type 1 diabetes mellitus. Metabolism 2001;50:657-660
  96. Jin RZ, Donaghue KC, Fairchild JM, Chan A, Silink M. Comparison of Dinamap 8100 with sphygmomanometer blood pressure measurement in a prepubertal diabetes cohort. J Paediatr Child Health 2001;37:545-549
  97. Handelsman P, Craig ME, Donaghue KC, Chan A, Blades B, Laina R, Bradford D, Middlehurst A, Ambler GR, Verge CF, Crock P, Moore P, Silink M. Homogeneity of metabolic control in NSW and ACT, Australia. for the NSW/ACT HbA1c Study Group Diabetes Care 2001;24:1690-1691
  98. Tyrrell VJ, Ambler GR, Yeow WH, Cowell CT, Silink M. Ten Years' Experience of Persistent Hyperinsulinaemic Hypoglycaemia of Infancy. J Paediatr Child Health 2001;37:483-488
  99. Silink M. How should we manage celiac disease in childhood diabetes? Pediatric Diabetes 2001;2:95-97
  100. Kao Y, Donaghue KC, Chan A, Bennetts BH, Knight J, Silink M. Paraoxonase gene cluster is a genetic marker for early microvascular complication in type 1 diabetes. Diabetic Med 2002;19:212-215
  101. Silink M. Childhood Diabetes: A Global Perspective. Hormone Research 2002;57(suppl 1):1-5
  102. Xiang H, Schevzov G, Gunning P, Williams M, Silink M. A Comparative Study of Growth-Inhibitory Effects of Isoflavones and Their Metabolites on Human Breast and Prostate Cancer Cell Lines. Nutrition and Cancer 2002;42(2), 224-232
  103. Craig ME, Handelsman P, Donaghue KC, Chan A, Blades B, Laina R, Bradford D, Middlehurst A, Ambler G, Verge CF, Crock P, Moore P, Silink M. HbA1c ACT: Predictors of glycaemic control and hypoglycaemia in children and adolescents with type 1 diabetes from NSW and the ACT. Med Journ of Aust 2002;177:235-238
  104. Buhler MM, Craig M, Donaghue KC, Badhwar P, Willis J, Manolio N, Tait BD, Silink M, Bennetts BH, Stewart GJ. Reduction in observed homozygous CCR5-delta 32 individuals in a type 1 diabetes cohort suggests partial protection for delta 32 homozygotes. Autoimmunity 2002;35:457-461
  105. Donaghue KC, Kordonouri O, Chan A, Silink M. Secular changes in growth in children with diabetes: are we winning? Archiv Dis Childhood 2003;88:151-154
  106. Craig ME, Robertson P, Howard NJ, Silink M, Rawlinson WD. Diagnosis of enterovirus infection by genus-specific PCR and Enzyme Linked Immunosorbent Assays. Journal Clin Micro 2003;41(2):841-844
  107. Donaghue KC, Fairchild JM, Craig ME, Chan AK, Hing S, Cutler LR, Howard NJ, Silink M. Do All Prepubertal Years of Diabetes Duration Contribute Equally to Diabetes Complications? Diabetes Care 2003;26(4):1224-1229
  108. Craig ME, Howard NJH, Silink M, Rawlinson WD. Enterovirus RNA is associated with a reduced frequency of HLA DRB1*03-DQB1*02 in children with type 1 diabetes. Journal of Infectious Diseases 2003;187:1562-1570
  109. Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M. Type 2 Diabetes in the Young: The Evolving Epidemic. Diabetes Care 2004;27(7):1798-1811
  110. Hu M, Zhang GY, Arbuckle S, Graf N, Shun A, Silink M, Lewis D, Alexander SI. Prophylactic bilateral nephrectomies in 2 paediatric patients with missense mutations in the WT1g. Nephrology Dialysis Transplantation 2004;19(1):223-226
  111. Kent A, Simpson E, Ellwood D, Silink M. A Case of XY Sex Reversal and Congenital Diaphragmatic Hernia. J Med Genetics 2004;131A(1):103-105
  112. Maguire A, Chan A, Cusumano J, Hing S, Craig M, Silink M, Howard N, Donaghue KC. The Case for Biennial Retinopathy Screening in Children and Adolescents Diabetes Care 2005; 28: 509-513.
  113. Donaghue KC, A Chan, J Fairchild, M Craig, J Cusumano, C Verge, P Crock, NJ Howard, M Silink. Prevalence of diabetes complications six years after diagnosis. Diabetic Med 2005;22:711-718
  114. Mohsin F, Craig ME, Cusumano J, Chan AK, Hing S, Lee JW, Silink M, Howard N, Donaghue KC. Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002, Diabetes Care 28:1974-1980, 2005
  115. Donaghue KC, Margan SH, Chan AK, Holloway B, Silink M, Rangel T, Bennetts B: The association of aldose reductase gene (AKR1B1) polymorphisms with diabetic neuropathy in adolescents. Diabet.Med. 22:1315-1320, 2005
  116. Donaghue KC, Craig ME, Chan AK, Fairchild JM, Cusumano JM, Verge CF, Crock PA, Hing SJ, Howard NJ, Silink M: Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of childhood diabetes. Diabet.Med. 22:711-718, 2005
  117. Taplin CE, Craig ME, Lloyd M, Taylor C, Crock P, Silink M, Howard NJ: The rising incidence of childhood type 1 diabetes in New South Wales, 1990-2002. Med.J.Aust. 183:243-246, 2005
  118. Taplin CE, Cowell CT, Silink M, Ambler GR: Fludrocortisone therapy in cerebral salt wasting. Pediatrics 118:e1904-e1908, 2006
  119. Eppens MC, Craig ME, Jones TW, Silink M, Ong S, Ping YJ: Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications. Curr.Med.Res.Opin. 22:1013-1020, 2006
  120. Savage MO, Cassorla FG, Gluckman PD, Grueters-Kieslich A, Raghupathy P, Silink M, Czernichow P, Chiarelli F, Rogol AD, Crock PA, Cowell CT, Fujieda K, Arnhold IJ: Global inequalities in paediatric endocrine practice: statement of minimal acceptable care. Statement from the international societies for paediatric endocrinology. Horm.Res. 65:111-113, 2006
  121. Thamotharampillai K, Chan AK, Bennetts B, Craig ME, Cusumano J, Silink M, Oates PJ, Donaghue KC: Decline in neurophysiological function after 7 years in an adolescent diabetic cohort and the role of aldose reductase gene polymorphisms. Diabetes Care 29:2053-2057, 2006
  122. Lefebvre P, Silink M: Diabetes fights for recognition. Lancet 368:1625-1626, 2006
  123. Hofer SE, Bennetts B, Chan AK, Holloway B, Karschimkus C, Jenkins AJ, Silink M, Donaghue KC: Association between PON 1 polymorphisms, PON activity and diabetes complications. J.Diabetes Complications 20:322-328, 2006
  124. Eppens MC, Craig ME, Cusumano J, Hing S, Chan AK, Howard NJ, Silink M, Donaghue KC: Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29:1300-1306, 2006
  125. Maguire AM, Craig ME, Craighead A, Chan AK, Cusumano JM, Hing SJ, Silink M, Howard NJ, Donaghue KC: Autonomic nerve testing predicts the development of complications: a 12-year follow-up study. Diabetes Care 30:77-82, 2007

Books

Silink M. (Ed), APEG Handbook on Childhood and Adolescent Diabetes. The Management of insulin-dependent diabetes mellitus. NSW Govt. Printer. 1996
Silink M, Dundar Y, Hatun S (Eds). Çocukluk Ve Ergenlik Döneminde Tip 1 Diyabet Elkitabi. Medico Graphics 1997
Silink M, Fichna P (Eds). Cukrzyca Wieku Dzieciecego 1 Okresu Dojrzewania. 1997
Silink M, Kida K, Rosenbloom. Type 2 Diabetes in Childhood & Adolescence - A global perspective. Martin Dunitz (London) 2003

Book Chapters

Silink M. Normal Growth. In Buchanan N, ed. Child and Adolescent Health for Practitioners. Williams & Wilkins & Assoc. Pty. Ltd., 1987;4:36-44
Silink M. Hypothalamic and Pituitary Disorders. Thong YH, ed. Textbook of Paediatric Practice, Sydney: Butterworth 1989:464-469
Silink M. Disorders of Parathyroid and Calcium Metabolism. Thong YH, ed. Textbook of Paediatric Practice, Sydney: Butterworth 1989:475-480
Silink M. Childhood Diabetes and Hypoglycaemia in Practical Paediatrics. Ed MJ Robinson. Churchill Livingstone 1990:480-487
Silink M & Vines R. A Decade of Change in the Management of Childhood Diabetes. Ed Procopis P & Kewley G. Current Paediatric Practice. Saunders WB 1991:231-233
Silink M. Childhood diabetes. Practical Paediatrics, 2nd edition, edited by Robinson & Robertson. Churchill Livingstone. 1993
Silink M. "Testing for control - home & hospital". Chapter 21, pp311-321, in "Childhood and adolescent diabetes". Edited by C Kelnar. Chapman and Hall, London. 1994
Silink M. The schoolchild with diabetes. In: Diabetes and you - owner's manual. published by Diabetes Australia 1993
Silink M. Sick Day Rules. Diabetes 1994 Editors : Shigeaki Baba Toshio Kaneko Publishers Elsevier Amsterdam 1995:1212-1226
Silink M. Foreword. Diabetes and the Adolescent. Eds Werther G, Court J. Publishers Miranova. Melbourne 1998
Silink M. Hypoglycaemia. Diabetes In the New Millenium. Eds Turtle JR, Kaneko T, Osato S. The Pot Still Press. Australia 1999
Barron V, Silink M. Diabetes education in childhood. The Diabetes Annual/12. Eds. Marshall SM, Home PD, Rizza RA. Elsevier Science BV. Great Britain 1999
Silink M. Diabetic Ketoacidosis in childhood and adolescence. The Oxford Textbook of Endocrinology and Diabetes. Eds Amiel S, Gale E. Oxford University Press. Oxford UK 2002
Silink M, Kida K, Rosenbloom. Introduction - global evolution of diabetes in children and adolescents. Type 2 Diabetes in Childhood & Adolescence - A global perspective. Martin Dunitz (London) 2003
Silink M, Kida K, Rosenbloom. Diagnosis and classification of type 2 diabetes in childhood and adolescence. Type 2 Diabetes in Childhood & Adolescence - A global perspective. Martin Dunitz (London) 2003

Interests

Major research interests

  • Epidemiology of type 1 diabetes in childhood and adolescence

  • Viral causes of type 1 diabetes

  • Natural history of microvascular complications in childhood and adolescent diabetes

  • Standards of care

  • Clinical guidelines for the management of type 1 diabetes

  • Type 1 diabetes in childhood in developing countries

  • Complications of type 1 diabetes in childhood in developing countries

  • The epidemiology of type 2 diabetes in childhood and adolescence

  • Lifestyle factors in the causation of type 2 diabetes in childhood

  • The metabolic syndrome, obesity and insulin resistance in childhood

Clinical guidelines

Evidence based clinical management guidelines for type 1 diabetes in childhood

Advocacy

  • IDF Child Sponsorship programme - Life for a Child with Diabetes (an international sponsorship programme to provide insulin, monitoring equipment, diabetes education and complications screening for children with type 1 diabetes in developing countries)

  • Delivery of clinical care in developing countries

  • Training of paediatric diabetes specialists in developing countries

This document was updated on Wednesday, 21 February 2007.
  table of contents copyright    disclaimer    privacy